רקורמון 2000 IU Izrael - hebrejščina - Ministry of Health

רקורמון 2000 iu

roche pharmaceuticals (israel) ltd - epoetin beta 2000 iu / 0.3 ml - solution for injection - erythropoietin - treatment of anemia associated with chronic renal failure (renal anemia) in patients on dialysis. treatment of symptomatic renal anemia in patients not yet undergoing dialysis. increasing the yield of autologous blood from patients in a pre-donation program. its use in this indication must be balanced against the reported increased risk of thromboembolic events. treatment should only be given to patients with moderate anemia (hb 10-13 g/dl (6.21- 8.07 mmol/l) no iron deficiency) or when blood conserving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males). treatment of anemia in adult patients with solid tumors and treated with platinum-based chemotherapy prone to induce anemia (cisplatin 75 mg/m2/cycle carboplatin: 350 mg/m2/cycle). treatment of anemia in adult patients with multiple myeloma low grade non-hodgkin's lymphoma or chronic lymphocytic leukemia who have a relative

רקורמון IU 3000 Izrael - hebrejščina - Ministry of Health

רקורמון iu 3000

roche pharmaceuticals (israel) ltd - epoetin beta 3000 iu / 0.3 ml - solution for injection - erythropoietin - treatment of anemia associated with chronic renal failure (renal anemia) in patients on dialysis. treatment of symptomatic renal anemia in patients not yet undergoing dialysis. increasing the yield of autologous blood from patients in a pre-donation program. its use in this indication must be balanced against the reported increased risk of thromboembolic events. treatment should only be given to patients with moderate anemia (hb 10-13 g/dl (6.21- 8.07 mmol/l) no iron deficiency) or when blood conserving procedures are not available or insufficient when the scheduled major elective surgery requires a large volume of blood (4 or more units of blood for females or 5 or more units for males). treatment of anemia in adult patients with solid tumors and treated with platinum-based chemotherapy prone to induce anemia (cisplatin 75 mg/m2/cycle carboplatin: 350 mg/m2/cycle). treatment of anemia in adult patients with multiple myeloma low grade non-hodgkin's lymphoma or chronic lymphocytic leukemia who have a relative

bare paltinum microcoil delivery system Izrael - hebrejščina - Ministry of Health

bare paltinum microcoil delivery system

"סיגמא בי.די בע""מ" - רופא - מערכת מיקרו-סליל פלטינום לטיפול במפרצות מוחיות

bare paltinum microcoil delivery system a Izrael - hebrejščina - Ministry of Health

bare paltinum microcoil delivery system a

סיגמא בי.די - רופא - מערכת מיקרו-סליל פלטינום לטיפול במפרצות מוחיות

מירסרה 250 מק"ג/ 0.3 מ"ל Izrael - hebrejščina - Ministry of Health

מירסרה 250 מק"ג/ 0.3 מ"ל

roche pharmaceuticals (israel) ltd - methoxy polyethylene glycol-epoetin beta 250 mcg / 0.3 ml - solution for injection - methoxy polyethylene glycol-epoetin beta - treatment of anemia associated with chronic kidney disease (ckd).

אפורציו IU 1000 Izrael - hebrejščina - Ministry of Health

אפורציו iu 1000

salomon,levin & elstein ltd - epoetin theta (r-huepo) 1000 iu / 0.5 ml - solution for injection - erythropoietin - - treatment of symptomatic anaemia associated with chronic renal failure in adult patients.- treatment of symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.

אפורציו IU 2000 Izrael - hebrejščina - Ministry of Health

אפורציו iu 2000

salomon,levin & elstein ltd - epoetin theta (r-huepo) 2000 iu / 0.5 ml - solution for injection - erythropoietin - - treatment of symptomatic anaemia associated with chronic renal failure in adult patients.- treatment of symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy.